J N Fiessinger Selected Research

J N Fiessinger Research Topics

3	Venous Thromboembolism 06/2000 - 02/2000
2	Peripheral Arterial Disease 11/2010 - 08/2004
2	Takayasu Arteritis (Arteritis, Takayasu's) 11/2001 - 09/2001
2	Pulmonary Embolism 01/2001 - 08/2000
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2001 - 01/2001
2	Thrombosis (Thrombus) 03/2000 - 02/2000
1	Thromboangiitis Obliterans (Buerger's Disease) 01/2010
1	Chronic Limb-Threatening Ischemia 12/2003
1	Embolism (Embolus) 01/2001
1	Intermittent Claudication 07/2000
1	Myocardial Infarction 03/2000
1	Coronary Thrombosis 03/2000
1	Protein S Deficiency (Deficiency, Protein S) 02/2000

2	Prothrombin (Factor II)IBA 08/2004 - 01/2001
1	terutrobanIBA 11/2010
1	ThromboxanesIBA 11/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2010
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	Factor V (Coagulation Factor V)IBA 08/2004
1	Biological ProductsIBA 09/2001
1	AnticoagulantsIBA 01/2001
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2001
1	factor V LeidenIBA 01/2001
1	melagatranIBA 01/2001
1	Phenobarbital (Luminal)FDA Link 08/2000
1	beraprostIBA 07/2000
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 07/2000
1	AntibodiesIBA 06/2000
1	Immunoglobulin G (IgG)IBA 06/2000
1	Thromboplastin (Tissue Factor)IBA 03/2000
1	NucleotidesIBA 03/2000
1	Antiphospholipid AntibodiesIBA 02/2000
1	AntithrombinsIBA 02/2000
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 02/2000
1	Anticardiolipin AntibodiesIBA 02/2000
1	Protein CIBA 02/2000
1	PAR-1 ReceptorIBA 02/2000
1	Thrombin FDA Link 02/2000
1	Thrombin Receptors (Thrombin Receptor)IBA 02/2000

1	Anesthesia 12/2003
1	Therapeutics 11/2001